Trials / Completed
CompletedNCT02861053
Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The chronic fatigue is observed in approximately 40 % of the patients with a chronic quiet inflammatory bowel disease (IBD) and impacts the quality of life of the patients. The beneficial role of a regular physical activity on the quality of life of patients having an IBD was demonstrated in 5 studies including only 1 controlled one \[Bilski, on 2013\]. The mechanism by which the physical activity could improve the quality of life of the patients remains unknown (stress decreased, reduction of the inflammatory process) \[Bilski, on 2014\]. Several studies concerning other chronic pathologies such as fibromyalgia, have demonstrated the beneficial effect of a regular physical exercise to reduce the fatigue of patients. It was recently demonstrated that the chronic fatigue observed in patients with IBD came along with a physical reduction in the performances during the exercise test and a reduction in the physical activity of the patients \[Vogelaar, 2015\]. Our hypothesis is that a regular moderate physical activity could improve physical performance during an effort et could reduce the chronic fatigue and improve their quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | regular and moderate physical activity | regular and moderate physical activity will be done 3 times per week more than usual |
| OTHER | No regular and moderate physical activity more than usual | regular and moderate physical activity will be done as usual |
Timeline
- Start date
- 2018-09-11
- Primary completion
- 2020-03-04
- Completion
- 2020-03-04
- First posted
- 2016-08-10
- Last updated
- 2026-01-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02861053. Inclusion in this directory is not an endorsement.